Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis-Reference-Cited by-同舟云学术

Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis

Published:2016-06 Issue:6 Volume:64 Page:1224-1231
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Foster Graham R.,Irving William L.,Cheung Michelle C.M.,Walker Alex J.,Hudson Benjamin E.,Verma Suman,McLauchlan John,Mutimer David J.,Brown Ashley,Gelson William T.H.,MacDonald Douglas C.,Agarwal Kosh

Publisher

Elsevier BV

Subject

Hepatology

Reference15 articles.

1. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection;Afdhal;N Engl J Med,2014

2. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection;Afdhal;N Engl J Med,2014

3. ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis;Poordad;N Engl J Med,2014

4. Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naïve patients: the COSMOS randomised study;Lawitz;Lancet,2014

5. Evaluation of sofosbuvir and simeprevir-based regimens in the TRIO network: academic and community treatment of a real-world, heterogeneous population;Dieterich;Hepatology,2014

Cited by 416 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of Clinical Trajectory in HCV-Related ACLD after SVR: Role of Liver Stiffness in a 5-Years Prospective Study;Viruses;2024-09-10

2. S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV);Zeitschrift für Gastroenterologie;2024-09

3. miRNA Expression and HCC Occurrence in HCV Cirrhotic Patients Treated with Direct Acting Antivirals;Livers;2024-05-31

4. Hepatocellular carcinoma after direct‐acting antivirals for hepatitis C is associated with KIR‐HLA types predicting weak NK cell‐mediated immunity;European Journal of Immunology;2024-05-03

5. Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals;Expert Opinion on Pharmacotherapy;2024-05-02